Home > Boards > US Listed > Medical - Healthcare > Mylan Inc. (MYL)

Probably due to the ISI webcast, which ended

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 727
Posts 110,573
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
Pfizer Sales Fall on Loss of Drug Exclusivity -- 2nd Update Dow Jones News - 1/28/2020 3:35:00 PM
Pfizer Sales Fall on Loss of Drug Exclusivity -- Update Dow Jones News - 1/28/2020 3:33:00 PM
Schedule 13g Edgar (US Regulatory) - 1/27/2020 1:29:47 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/24/2020 5:01:36 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/22/2020 4:46:16 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/16/2020 8:31:29 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/15/2020 4:32:49 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/15/2020 4:32:46 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 1/15/2020 4:32:36 PM
Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts ... PR Newswire (US) - 1/8/2020 10:30:00 AM
Mylan to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire (US) - 1/6/2020 7:30:00 AM
Mylan, Micro Labs Generics of Eliquis Approved by FDA Dow Jones News - 12/23/2019 4:02:00 PM
Shareholder Alert: Robbins LLP Announces Mylan N.V. (MYL) Sued for Misleading Shareholders Business Wire - 12/20/2019 12:56:00 PM
Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Mylan N.V. PR Newswire (US) - 12/19/2019 2:12:00 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/18/2019 4:35:46 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/18/2019 4:31:55 PM
Pfizer and Mylan Announce Two Future Viatris Board Members Business Wire - 12/18/2019 8:30:00 AM
Pfizer and Mylan Announce Two Future Viatris Board Members PR Newswire (US) - 12/18/2019 8:30:00 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 12/4/2019 5:26:30 PM
Mylan and Biocon Launch Trastuzumab Biosimilar, Ogivri™ (trastuzumab-dkst), in the U.S. PR Newswire (US) - 12/2/2019 7:00:00 AM
Mylan to Present at the Evercore ISI HealthCONx Conference PR Newswire (US) - 11/25/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2019 4:32:20 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 11/12/2019 5:00:05 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 11/12/2019 4:47:04 PM
Mylan and Pfizer Say Combined Mylan-Upjohn to Be Called Viatris Dow Jones News - 11/12/2019 1:22:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist